News Highlights
Research led by UAB’s Institute for Cancer Outcomes and Survivorship and director Smita Bhatia, M.D., MPH finds that patients who received autologous blood or marrow transplantation (using their own cells) over the past three decades lived on average seven years fewer than peers. But newer strategies have narrowed the mortality gap, they report in the Journal of Clinical Oncology.
Latest Headlines
-
Genetic variant linked with increased risk of anthracycline-related cardiomyopathy
Childhood cancer survivors with two genetic variations on the ROBO2 gene and who were treated with high doses of anthracycline treatment have a higher risk of developing cardiomyopathy. -
Financial burdens exacerbated by COVID-19 affect health outcomes in BMT survivors
The study suggests that BMT survivors were more likely to be unable to afford basic necessities, and to defer medical care, in the wake of the COVID-19 pandemic. -
In-person UAB commencement set for Bartow Arena on April 29, 30
More than 2,600 students will graduate from UAB this spring. Approximately 1,600 students will walk in one of the university’s three ceremonies. -
Study provides ‘critical information’ for treating childhood cancer patients with COVID
The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors[…] -
Study first to demonstrate that HPV vaccines are safe and generate protective antibody levels in young cancer survivors
Young cancer survivors are at higher risk of developing subsequent HPV-related cancers than the general population, but less likely to receive the HPV vaccine. Findings from the first clinical trial of its kind support making HPV vaccination a routine part[…] -
Life expectancy, outcomes improving after BMT but still behind general population, study finds
Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship. -
$100 million in contributions to transform UAB School of Medicine
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation. -
How does COVID-19 affect patients with cancer? Largest U.S. study shares first results
New findings include a significant increase in risk of death among patients who had recently had chemotherapy. -
Dr. Bhatia Elected to APS Membership & COG Executive Committee Member At-Large
Congratulations to Smita Bhatia, M.D., M.P.H., on her election to membership in the American Pediatric Society (APS). Dr. Bhatia and other new members will be honored during the 2016 PAS meeting in Baltimore, MD, in May 2016. The mission of the American Pediatric[…]
-
ICOS Director, Dr. Bhatia, Selected to Participate in Blue Ribbon Panel
The National Cancer Institute (NCI) and the Blue Ribbon Panel (BRP) has invited Smita Bhatia, M.D., MPH, Pediatric Hematology and Oncology, to participate in the BRP Working Group on Pediatric Cancer. Through participation, Dr. Bhatia will be filling an essential[…]
Latest Tweets
Upcoming Events
